|
1
|
Chen J and Stubbe J: Bleomycins: towards
better therapeutics. Nat Rev Cancer. 5:102–112. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Okamura Y, Nomoto S, Hayashi M, et al:
Identification of the bleomycin hydrolase gene as a methylated
tumor suppressor gene in hepatocellular carcinoma using a novel
triple-combination array method. Cancer Lett. 312:150–157. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Towne CF, York IA, Watkin LB, Lazo JS and
Rock KL: Analysis of the role of bleomycin hydrolase in antigen
presentation and the generation of CD8 T cell responses. J Immunol.
178:6923–6930. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Suszynska J, Tisonczyk J, Lee HG, Smith MA
and Jakubowski H: Reduced homocysteine-thiolactonase activity in
Alzheimer’s disease. J Alzheimers Dis. 19:1177–1183.
2010.PubMed/NCBI
|
|
5
|
Lefterov IM, Koldamova RP and Lazo JS:
Human bleomycin hydrolase regulates the secretion of amyloid
precursor protein. FASEB J. 14:1837–1847. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zimny J, Sikora M, Guranowski A and
Jakubowski H: Protective mechanisms against homocysteine toxicity:
the role of bleomycin hydrolase. J Biol Chem. 281:22485–22492.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ratovitski T, Chighladze E, Waldron E,
Hirschhorn RR and Ross CA: Cysteine proteases bleomycin hydrolase
and cathepsin Z mediate N-terminal proteolysis and toxicity of
mutant huntingtin. J Biol Chem. 286:12578–12589. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kamata Y, Taniguchi A, Yamamoto M, Nomura
J, Ishihara K, Takahara H, Hibino T and Takeda A: Neutral cysteine
protease bleomycin hydrolase is essential for the breakdown of
deiminated filaggrin into amino acids. J Biol Chem.
284:12829–12836. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ferrando AA, Pendás AM, Llano E, Velasco
G, Lidereau R and López-Otín C: Gene characterization, promoter
analysis, and chromosomal localization of human bleomycin
hydrolase. J Biol Chem. 272:33298–33304. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ferrando AA, Velasco G, Campo E and
Lopez-Otin C: Cloning and expression analysis of human bleomycin
hydrolase, a cysteine proteinase involved in chemotherapy
resistance. Cancer Res. 56:1746–1750. 1996.PubMed/NCBI
|
|
11
|
Brömme D, Rossi AB, Smeekens SP, Anderson
DC and Payan DG: Human bleomycin hydrolase: molecular cloning,
sequencing, functional expression, and enzymatic characterization.
Biochemistry. 35:6706–6714. 1996.PubMed/NCBI
|
|
12
|
Montoya SE, Ferrell RE and Lazo JS:
Genomic structure and genetic mapping of the human neutral cysteine
protease bleomycin hydrolase. Cancer Res. 57:4191–4195.
1997.PubMed/NCBI
|
|
13
|
Chen J, Chen Y and He Q: Action of
bleomycin is affected by bleomycin hydrolase but not by caveolin-1.
Int J Oncol. 41:2245–2252. 2012.PubMed/NCBI
|
|
14
|
Lazo JS, Boland CJ and Schwartz PE:
Bleomycin hydrolase activity and cytotoxicity in human tumors.
Cancer Res. 42:4026–4031. 1982.PubMed/NCBI
|
|
15
|
Schwartz DR, Homanics GE, Hoyt DG, Klein
E, Abernethy J and Lazo JS: The neutral cysteine protease bleomycin
hydrolase is essential for epidermal integrity and bleomycin
resistance. Proc Natl Acad Sci USA. 96:4680–4685. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
De Haas EC, Zwart N, Meijer C, et al:
Variation in bleomycin hydrolase gene is associated with reduced
survival after chemotherapy for testicular germ cell cancer. J Clin
Oncol. 26:1817–1823. 2008.PubMed/NCBI
|
|
17
|
Timmer JC and Salvesen GS: Caspase
substrates. Cell Death Differ. 214:66–72. 2007. View Article : Google Scholar
|
|
18
|
Crawford ED and Wells JA: Caspase
substrates and cellular remodeling. Annu Rev Biochem. 80:1055–1087.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu G, Cirilli M, Huang Y, Rich RL, Myszka
DG and Wu H: Covalent inhibition revealed by the crystal structure
of the caspase-8/p35 complex. Nature. 410:494–497. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Koldamova RP, Lefterov IM, DiSabella MT
and Lazo JS: An evolutionarily conserved cysteine protease, human
bleomycin hydrolase, binds to the human homologue of
ubiquitin-conjugating enzyme 9. Mol Pharmacol. 54:954–961.
1998.PubMed/NCBI
|
|
21
|
Schwanhäusser B, Busse D, Li N, Dittmar G,
Schuchhardt J, Wolf J, et al: Global quantification of mammalian
gene expression control. Nature. 473:337–342. 2011.
|
|
22
|
Pei Z, Calmels TP, Creutz CE and Sebti SM:
Yeast cysteine proteinase gene ycp1 induces resistance to bleomycin
in mammalian cells. Mol Pharmacol. 48:676–681. 1995.PubMed/NCBI
|
|
23
|
Montoya SE, Thiels E, Card JP and Lazo JS:
Astrogliosis and behavioral changes in mice lacking the neutral
cysteine protease bleomycin hydrolase. Neuroscience. 146:890–900.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chaitanya GV, Steven AJ and Babu PP:
PARP-1 cleavage fragments: signatures of cell-death proteases in
neurodegeneration. Cell Commun Signal. 8:312010. View Article : Google Scholar : PubMed/NCBI
|
